| Literature DB >> 33368246 |
Hailan Liu1,2, Yang He1, Jessie Beck1, Silvania da Silva Teixeira3, Keisha Harrison4, Yong Xu1, Stephanie Sisley1.
Abstract
Vitamin D action has been linked to several diseases regulated by the brain including obesity, diabetes, autism, and Parkinson's. However, the location of the vitamin D receptor (VDR) in the brain is not clear due to conflicting reports. We found that two antibodies previously published as specific in peripheral tissues are not specific in the brain. We thus created a new knockin mouse with cre recombinase expression under the control of the endogenous VDR promoter (VDRCre ). We demonstrated that the cre activity in the VDRCre mouse brain (as reported by a cre-dependent tdTomato expression) is highly overlapping with endogenous VDR mRNAs. These VDR-expressing cells were enriched in multiple brain regions including the cortex, amygdala, caudate putamen, and hypothalamus among others. In the hypothalamus, VDR partially colocalized with vasopressin, oxytocin, estrogen receptor-α, and β-endorphin to various degrees. We further functionally validated our model by demonstrating that the endogenous VDR agonist 1,25-dihydroxyvitamin D activated all tested tdTomato+ neurons in the paraventricular hypothalamus but had no effect on neurons without tdTomato fluorescence. Thus, we have generated a new mouse tool that allows us to visualize VDR-expressing cells and to characterize their functions.Entities:
Keywords: RRID:AB_141637; RRID:AB_2157629; RRID:AB_2314007; RRID:AB_2715552; RRID:AB_2832252; RRID:AB_310305; RRID:AB_628040; RRID:AB_632069; brain; immunohistochemistry; mutant mouse strain; vitamin D receptor
Mesh:
Substances:
Year: 2021 PMID: 33368246 PMCID: PMC8053677 DOI: 10.1002/cne.25100
Source DB: PubMed Journal: J Comp Neurol ISSN: 0021-9967 Impact factor: 3.028